Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2015
FDA approves Darzalex for patients with previously treated multiple myeloma
16 November 2015 - Today the U.S. FDA granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who ...
Posted by Michael Wonder on 14 Nov 2015
FDA approves new pill to treat certain patients with non-small cell lung cancer
13 November 2015 - Today, the U.S. FDA granted accelerated approval for Tagrisso (osimertinib) for patients whose tumors have a specific ...
Posted by Michael Wonder on 12 Nov 2015
FDA approves Cotellic as part of combination treatment for advanced melanoma
10 November 2015 - The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib ...
Posted by Michael Wonder on 05 Nov 2015
FDA approves new treatment for HIV
5 November 2015 - The U.S. FDA today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) ...
Posted by Michael Wonder on 05 Nov 2015
FDA approves Nucala to treat severe asthma
4 November 2015 - The U.S. FDA has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment ...
Posted by Michael Wonder on 02 Nov 2015
Merck receives breakthrough therapy designation from U.S. Food and Drug Administration for Keytruda (pembrolizumab) in advanced colorectal cancer
2 November 2015 - This is the third breakthrough therapy designation granted for Keytruda. ...
Posted by Michael Wonder on 29 Oct 2015
FDA approves Yervoy to reduce the risk of melanoma returning after surgery
28 October 2015 - Today the U.S. Food and Drug Administration expanded the approved use of Yervoy (ipilimumab) to include a ...
Posted by Michael Wonder on 27 Oct 2015
FDA approves first-of-its-kind product for the treatment of melanoma
27 October 2015 - The U.S. Food and Drug Administration today approved Imlygic (talimogene laherparepvec), the first FDA-approved oncolytic virus therapy, ...
Posted by Michael Wonder on 26 Oct 2015
FDA approves new therapy for certain types of advanced soft tissue sarcoma
23 October 2015 - The U.S. Food and Drug Administration today approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific ...
Posted by Michael Wonder on 23 Oct 2015
FDA approves new treatment for rare metabolic disorder
23 October 2015 - The U.S. Food and Drug Administration has approved Strensiq (asfotase alfa) as the first approved treatment for ...
Posted by Michael Wonder on 22 Oct 2015
FDA approves new treatment for advanced pancreatic cancer
22 October 2015 - The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and ...
Posted by Michael Wonder on 22 Oct 2015
FDA approves new drug to treat patients with hyperkalaemia
21 October 2015 - The U.S. Food and Drug Administration today approved Veltassa (patiromer) to treat patients with hyperkalaemia. ...
Posted by Michael Wonder on 20 Oct 2015
FDA approves first Factor X concentrate to treat patients with rare hereditary bleeding disorder
20 October 2015 - The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X ...
Posted by Michael Wonder on 16 Oct 2015
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa
16 October 2015 - The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients ...
Posted by Michael Wonder on 09 Oct 2015
FDA expands approved use of Opdivo in advanced lung cancer
9 October 2015 - The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small ...